Avaaz petitie: IARC, WHO: Radio Frequency Radiation from Class 2b to Class 1

zondag, 21 december 2014 - Categorie: Oproepen

Bron: secure.avaaz.org/en/petition/IARC_WHO_Move_Radio_Frequency_Radiation_from_Class_2b_to_Class_1/?awtbXdb .
nov. 2014

IARC, WHO: Move Radio Frequency Radiation from Class 2b to Class 1

Dat zouden we allemaal direct willen. Tekenen s.v.p. (zie bovenstaande link)
Op 22 dec. 2014 waren er 3702 ondertekenaars en het aantal groeit nog steeds.
Voor wie Avaaz niet kent, dat is een uiterst betrouwbare organisatie.

Met nog een aanmoediging om te ondertekenen van Lennart Hardell:

lennarthardellenglish.wordpress.com/2014/12/08/moving-radiofrequency-radiation-from-group-2b-to-1-as-a-human-carcinogen/ .

Moving radiofrequency radiation from Group 2B to 1 as a human carcinogen

The carcinogenic effect of radiofrequency electromagnetic fields (RF-EMF) on humans was evaluated at a meeting during 24 – 31 May 2011 at the International Agency for Research on Cancer (IARC) at WHO in Lyon, France. The Working Group categorised RF-EMF from mobile phones, and from other devices that emit similar non-ionising electromagnetic fields, as a Group 2B, i.e. a ‘possible’, human carcinogen.

After that meeting supportive evidence has come from e.g. the French CERENAT study and also our recent publication on glioma. An increased risk for acoustic neuroma associated with use of wireless phones was published by our research group after the meeting giving pooled results of our study periods 1997-2003 and 2007-2009. Also other studies have reported similar findings.

We evaluated the Hill viewpoints on association and causation used in the 1960’s in the debate on lung cancer risk among smokers. Using these viewpoints our summary was that RF-EMF exposure should be a Group 1 carcinogen according to IARC criteria. There is now a petition to support that notion aiming at alerting IARC to classify such exposure to cause human cancer. Those who want to support the petition can follow this (bovenste) link.

Zie ook:
www.ncbi.nlm.nih.gov/pubmed/24192496 .

Lees verder in de categorie Oproepen | Terug naar homepage | Lees de introductie